Restart Life Sciences Corp. (NMLSF)
OTCMKTS
· Delayed Price · Currency is USD
0.0570
+0.0220 (62.86%)
May 12, 2025, 4:00 PM EDT
Restart Life Sciences Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.43M USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| BioStem Technologies | 332.45M |
Restart Life Sciences News
- 2 months ago - Restart Life Expands Intellectual Property Through Trademark Licensing Agreement - Newsfile Corp
- 3 months ago - Restart Life Secures Strategic Production Partner - Newsfile Corp
- 3 months ago - Restart Life Announces Key Business Updates - Newsfile Corp
- 3 months ago - Restart Life Sciences Corp. Relies on Exception Under CSE Policy 4.6(2)(b) for Previously Closed Private Placement and Debt Settlement Transactions and Announces Debt Settlement Transaction - Newsfile Corp
- 9 months ago - Nova Mentis Assigns Intellectual Property - Newsfile Corp
- 10 months ago - CSE Bulletin: WITHDRAWN - Symbol Change - Inactive Designation - Nova Mentis Life Science Corp. (NOVA) - Newsfile Corp
- 10 months ago - CSE Bulletin: Symbol Change - Inactive Designation - Nova Mentis Life Science Corp. (NOVA) - Newsfile Corp
- 1 year ago - Nova Mentis Announces Change of Directors - Newsfile Corp